Synopsis
Recognise the broad and sometimes delayed presentation of pelvic-mesh complications, document the implant accurately, investigate according to symptoms and connect patients with regional multidisciplinary specialist care.
- Ask whether the implant was a mid-urethral continence sling, transvaginal prolapse mesh, abdominal sacrocolpopexy or sacrohysteropexy mesh, or rectopexy mesh; route and site determine likely complications and expertise.
- Possible symptoms include pain or altered sensation, vaginal bleeding or discharge, dyspareunia or partner pain, recurrent infection, leakage, retention or painful voiding, and bowel symptoms; onset can be delayed by years.
- A normal vaginal examination does not exclude mesh contraction, deep infection, nerve or musculoskeletal pain, or mesh within bladder or bowel.
- Take a complete implant and removal history and obtain operation notes, product labels, prior imaging, cystoscopy and pathology whenever possible.
- NICE advises specialist referral for suspected mesh complications and regional mesh-centre referral for confirmed complications or unexplained symptoms after mesh.
- Choose examination under anaesthesia, cystourethroscopy, expert MRI or ultrasound, CT, contrast studies, flow and residual, cystometry or neurophysiology only when the result answers a defined question.
- For one vaginal exposure smaller than 1 cm², discuss topical vaginal oestrogen and follow up within three months; larger, extruded, persistent or treatment-declined exposure needs removal discussion.
- Mesh removal may be partial, complete only as far as safely possible, staged or not appropriate; it may not relieve symptoms and can create organ injury, recurrent incontinence or prolapse and new urinary, bowel or sexual dysfunction.
- Record confirmed complications in the relevant registry and report suspected device incidents to the MHRA Yellow Card system; surveillance and active treatment should proceed in parallel.
Key red flags
Fever, rigors, hypotension, pelvic collection, peritonism or offensive discharge suggesting deep infection or abscess.
Acute retention, hydronephrosis, renal impairment, recurrent pyelonephritis or inability to catheterise after continence mesh.
Pneumaturia, faecaluria, faeces or urine through the vagina, bowel obstruction or concern for bladder, ureteric or bowel perforation.
Heavy vaginal or rectal bleeding, haematuria or unexplained anaemia.
Progressive leg weakness, saddle sensory loss, severe new neurological deficit or cauda-equina features.
Severe escalating pelvic, abdominal, groin, back, perineal or leg pain with systemic deterioration.
A visible implant with tissue necrosis, extensive extrusion or rapidly worsening wound breakdown.
New symptoms after mesh in a person with previous pelvic malignancy or radiotherapy, where recurrence and injury both need evaluation.
Investigation priorities
Identify every implant, route, date, site and prior partial removal before interpreting symptoms or planning surgery.
Management branches
New pain, vaginal, urinary, bowel, sexual or infection symptoms occur after any pelvic mesh procedure.
- Screen for sepsis, retention, renal injury, obstruction, fistula, bleeding and neurological deficit and use an urgent pathway when present.
- Take a complete implant and symptom history, request operation records, and perform only consented examinations relevant to the presentation.
- Refer to urogynaecology, urology or colorectal expertise; use a regional mesh centre for confirmed complications or unexplained symptoms after mesh.